SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 120 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $53,000 | -49.0% | 5,014 | -47.1% | 0.05% | -41.9% |
| Q1 2017 | $104,000 | -68.9% | 9,483 | -61.5% | 0.09% | -37.2% |
| Q4 2016 | $334,000 | +93.1% | 24,657 | +75.1% | 0.14% | +19.1% |
| Q3 2016 | $173,000 | -7.0% | 14,084 | -17.1% | 0.12% | -16.7% |
| Q2 2016 | $186,000 | -41.5% | 16,984 | -41.7% | 0.14% | -37.3% |
| Q1 2016 | $318,000 | – | 29,138 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
| Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
| First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
| NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
| HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
| Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
| BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |